newsletter due, page-3

Orion,
One problem CST have is they cant always give shareholders as much info as we would like as they have competition.I would imagine a lot of their research work is secret.

As to what improvements they are working on , well a QFT test which was able to tell if a patient had Active or Latent TB would be a world first.

Everything seems great apart from the share price, for it to move the market needs to see this quarters result which should be outstanding.

Hate to say it but looks like we will have to continue the waiting game.

Regards,